PREDILIFE
ALPRE | PA
Overview
Corporate Details
- ISIN(s):
- FR0010169920 (+5 more)
- LEI:
- 9695006IK5NBKHQU9116
- Country:
- France
- Address:
- 39 RUE CAMILLE DESMOULINS, 94800 VILLEJUIF
- Website:
- https://www.predilife.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Pioneers of predictive medicine in France, we position ourselves as a player in 6P medicine: Predictive, Preventive, Personalized, Participative, Relevant, Multi-professional. After 14 years of research and development, Predilife obtained its medical device certification and began marketing predictive assessments: predictive breast cancer assessment, multi-pathology predictive assessments. At Predilife, we are passionate about serving health, a committed team that works every day to change the rules so that our motto "predict to prevent" is adopted by the greatest number of people. We accompany companies, healthcare professionals and employees towards the medicine of tomorrow: predictive, personalized and digital. We are working to make predictive medicine accessible to everyone in order to reduce the number of serious diseases. We believe that predictive medicine will enable effective prevention and thus reduce the risk of serious diseases.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for PREDILIFE.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-22 19:00 |
Capital/Financing Update
PREDILIFE ANNONCE LA RÉALISATION D'UN PLACEMENT PRIVE DE 300 K EUR PERMETTANT D…
|
French | 498.0 KB | |
| 2025-06-11 19:00 |
Capital/Financing Update
Avenant au contrat de liquidité conclu avec TSAF
|
French | 164.0 KB | |
| 2025-06-06 20:15 |
Report Publication Announcement
Mise à disposition du rapport financier annuel 2024
|
French | 383.3 KB | |
| 2025-05-15 08:00 |
Earnings Release
RÉSULTATS ANNUELS 2024 - PERSPECTIVES DE CROISSANCE ET DE PARTENARIAT 2025
|
French | 283.1 KB | |
| 2025-04-30 18:30 |
Report Publication Announcement
REPORT DE LA PUBLICATION DES RESULTATS ANNUELS 2024 ET DU RAPPORT FINANCIER ANN…
|
French | 162.4 KB | |
| 2025-01-17 18:00 |
Regulatory News Service
Bilan semestriel au 31/12/2024 du contrat de liquidité PREDILIFE
|
French | 417.3 KB | |
| 2025-01-08 18:30 |
Earnings Release
PREDILIFE DOUBLE SON VOLUME DE VENTE EN 2024 ET ANTICIPE UNE FORTE CROISSANCE P…
|
French | 248.6 KB | |
| 2024-12-17 20:00 |
Capital/Financing Update
PREDILIFE ANNONCE LA RÉALISATION D'UNE LEVÉE DE FONDS DE 779 000 EUROS DANS LE …
|
French | 396.7 KB | |
| 2024-11-12 08:30 |
Capital/Financing Update
Predilife lance une émission d'obligations de 2M EUR à un taux de 8,5% par an s…
|
French | 898.9 KB | |
| 2024-11-07 18:30 |
M&A Activity
Réalisation de l'apport partiel d'actif de MammoRisk à une valorisation de 202 …
|
French | 225.6 KB | |
| 2024-10-30 19:00 |
Report Publication Announcement
Predilife met à disposition son rapport financier semestriel 2024
|
French | 158.4 KB | |
| 2024-10-28 08:30 |
Earnings Release
Résultats semestriels 2024 - Perspectives de croissance 2024
|
French | 256.4 KB | |
| 2024-10-21 18:30 |
Environmental & Social Information
Le Groupe Rocher prend une initiative majeure pour la santé des femmes et propo…
|
French | 236.4 KB | |
| 2024-10-02 20:30 |
M&A Activity
Signature du traité d'apport partiel d'actif relatif à la filialisation de Mamm…
|
French | 707.6 KB | |
| 2024-07-19 18:00 |
Regulatory News Service
Bilan semestriel au 30/06/2024 du contrat de liquidité PREDILIFE
|
French | 797.7 KB |
Automate Your Workflow. Get a real-time feed of all PREDILIFE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for PREDILIFE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-30 | N/A | Other | Buy | 200 | 960.00 EUR |
| 2024-07-04 | N/A | Other | Buy | 400 | 2,720.00 EUR |
| 2024-06-26 | N/A | Other | Buy | 2,000 | 12,000.00 EUR |
| 2024-06-18 | N/A | Other | Buy | 500 | 2,800.00 EUR |
| 2024-05-02 | N/A | Other | Sell | 8,500 | 204,000.00 EUR |
| 2024-04-26 | N/A | Other | Buy | 599 | 2,635.60 EUR |
| 2024-02-28 | N/A | Other | Buy | 1,600 | 6,720.00 EUR |
| 2024-02-26 | N/A | Other | Buy | 500 | 2,150.00 EUR |
| 2024-02-22 | N/A | Other | Buy | 500 | 2,250.00 EUR |
| 2024-02-20 | N/A | Other | Other | 1,000 | 4,800.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
| Incanthera plc | United Kingdom | N/A | ||
|
Inify Laboratories AB | Sweden | INIFY | |
|
Innate Pharma | France | IPH | |
|
IntegraGen | France | ALINT | |
|
INTERNATIONAL BIOTECHNOLOGY TST PLC | United Kingdom | IBT | |
|
Inventiva | France | IVA | |
|
IRLAB Therapeutics | Sweden | IRLAB | |
|
Isofol Medical | Sweden | ISOFOL | |
|
Jonix | Italy | JNXI | |
|
Kadimastem Ltd. | Israel | KDST |